Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1672 participants
INTERVENTIONAL
2011-09-30
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single WEB intervention
Web intervention recieved once.
Single WEB intervention
Brief WEB intervention recieved once
Repeated WEB intervention
Web intervention recieved twice.
Repeated WEB intervention
WEB intervention recieved twice.
Single IVR intervention
IVR intervention recieved once
Single IVR intervention
IVR intervention recieved once
Repeated IVR intervention
IVR intervention recieved twice
Repeated IVR intervention
IVR intervention recieved twice
Control group
Untreated Control Group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single WEB intervention
Brief WEB intervention recieved once
Repeated WEB intervention
WEB intervention recieved twice.
Single IVR intervention
IVR intervention recieved once
Repeated IVR intervention
IVR intervention recieved twice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claes Andersson
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claes Andersson, PhD
Role: PRINCIPAL_INVESTIGATOR
Malmö University, Department of Criminology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Malmö university, Department of Criminology
Malmo, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006/100
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
FHI 2006/100
Identifier Type: -
Identifier Source: org_study_id